LTBR

Lightbridge CEO Seth Grae Attends White House Summit on Domestic Nuclear Deployment

Retrieved on: 
Jeudi, mai 30, 2024

RESTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that its Chairman and CEO, Seth Grae, attended the White House Summit on Domestic Nuclear Deployment (the “Summit”), hosted by the Biden-Harris Administration.

Key Points: 
  • RESTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that its Chairman and CEO, Seth Grae, attended the White House Summit on Domestic Nuclear Deployment (the “Summit”), hosted by the Biden-Harris Administration.
  • The White House Summit underscored the Administration's commitment to bolstering the nuclear sector as a cornerstone of the nation’s strategy to achieve net-zero emissions and enhance energy security.
  • The White House Summit brought together leaders from the nuclear industry, government, and academia to discuss the role of nuclear energy in the United States' energy policy.
  • Seth Grae, Chairman & Chief Executive Officer of Lightbridge Corporation, commented, “I was honored to represent Lightbridge at such a pivotal event for the domestic nuclear industry.

Lightbridge Provides Business Update and Announces First Quarter 2024 Financial Results

Retrieved on: 
Jeudi, mai 9, 2024

RESTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the first quarter ended March 31, 2024, and provided an update on the Company’s continued progress.

Key Points: 
  • RESTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the first quarter ended March 31, 2024, and provided an update on the Company’s continued progress.
  • Cash provided by financing activities for the first quarter ended March 31, 2024 was $1.2 million, an increase of $0.5 million, compared to $0.7 million for the first quarter ended March 31, 2023.
  • General and administrative expenses amounted to $2.2 million for the first quarter ended March 31, 2024, compared to $1.9 million for the first quarter ended March 31, 2023.
  • Net loss was $2.8 million for the first quarter ended March 31, 2024, compared to $2.0 million for the first quarter ended March 31, 2023.

Ambassador Thomas Graham, Jr. Appointed As Chairman Emeritus of Lightbridge Corporation

Retrieved on: 
Jeudi, avril 18, 2024

RESTON, Va., April 18, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Ambassador Thomas Graham, Jr. will be retiring as Executive Chairman and director of Lightbridge effective as of the upcoming Annual Meeting of Shareholders.

Key Points: 
  • RESTON, Va., April 18, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Ambassador Thomas Graham, Jr. will be retiring as Executive Chairman and director of Lightbridge effective as of the upcoming Annual Meeting of Shareholders.
  • Ambassador Graham has been appointed Chairman Emeritus.
  • “I am honored to accept the appointment as Chairman Emeritus of Lightbridge,” said Ambassador Graham.
  • As he transitions to the role of Chairman Emeritus, we look forward to continuing to benefit from his wisdom and guidance.

Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce Tertiary Lymphoid Structures in Tumors

Retrieved on: 
Lundi, avril 8, 2024

The poster titled “Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors” is being presented as part of the “Late-Breaking Research: Immunology 2” poster session (9:00 a.m. – 12:30 p.m. PT, poster section 52; board number 11).

Key Points: 
  • The poster titled “Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors” is being presented as part of the “Late-Breaking Research: Immunology 2” poster session (9:00 a.m. – 12:30 p.m. PT, poster section 52; board number 11).
  • The presented data demonstrate that Mestag’s bispecific antibody co-engages fibroblast activated protein (FAP) and LTBR to conditionally activate LTBR and induce Tertiary Lymphoid Structures (TLS) in the tumor.
  • In vivo data showed potent monotherapy efficacy as well as tumor regression in combination with tumor antigen or a checkpoint inhibitor.
  • Ray Jupp, PhD, Chief Scientific Officer of Mestag Therapeutics, said, “TLS is an exciting new area of anti-cancer immunology.

Lightbridge Senior Executives Assume Key Positions in Prestigious Nuclear Energy Industry Groups

Retrieved on: 
Jeudi, mars 21, 2024

RESTON, Va., March 21, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced the appointments of senior Lightbridge executives within leading U.S. nuclear energy industry groups.

Key Points: 
  • RESTON, Va., March 21, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced the appointments of senior Lightbridge executives within leading U.S. nuclear energy industry groups.
  • Seth Grae, President and CEO of Lightbridge, has been appointed as the Chair of the American Nuclear Society’s (ANS) International Council.
  • Through educational programs, industry insights, and market intelligence, USNIC facilitates collaboration between legislators across political lines, promoting nuclear energy as a key component of a successful clean energy paradigm.
  • Mr. Grae discussed the growth and future prospects of nuclear power on the eve of the first-ever Nuclear Energy Summit in Brussels.

Lightbridge Achieves Critical Fabrication Development Milestone by Demonstrating the Extrusion Process for Uranium-Zirconium Samples

Retrieved on: 
Lundi, mars 18, 2024

Idaho National Laboratory (INL) has extruded coupon samples of Lightbridge Fuel™ material consisting of an alloy of depleted uranium and zirconium.

Key Points: 
  • Idaho National Laboratory (INL) has extruded coupon samples of Lightbridge Fuel™ material consisting of an alloy of depleted uranium and zirconium.
  • The extrusion process involves pressing a metallic alloy billet through a die.
  • The data will support fuel performance modeling and regulatory licensing efforts for the commercial deployment of Lightbridge Fuel.
  • “We are pleased to collaborate with Lightbridge in achieving this important milestone in their efforts to qualify Lightbridge fuel,” said Jess Gehin, INL associate laboratory director for Nuclear Science and Technology.

Lightbridge Announces Upcoming Nuclear Events

Retrieved on: 
Mercredi, mars 13, 2024

RESTON, Va., March 13, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Lightbridge President and CEO Seth Grae will participate in a series of upcoming nuclear events.

Key Points: 
  • RESTON, Va., March 13, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that Lightbridge President and CEO Seth Grae will participate in a series of upcoming nuclear events.
  • IAEA Nuclear Energy Summit 2024, Brussels, Belgium – Thursday, March 21
    World leaders will gather in Brussels at the first ever Nuclear Energy Summit to highlight the role of nuclear energy in addressing the global challenges to reduce the use of fossil fuels, enhance energy security and boost economic development.
  • The conference aims to provide a platform for international experts from vendors, utilities, research laboratories, and universities to exchange ideas and latest developments on a wide spectrum of topics.
  • For more information on the panel, visit: https://www.ans.org/meetings/physor2024/session/view-2379/

Mestag Therapeutics’ M300 Program, Designed to Conditionally Induce Tertiary Lymphoid Structures in Tumors, Selected for Late-Breaking Poster Presentation at AACR Annual Meeting

Retrieved on: 
Mardi, mars 5, 2024

CAMBRIDGE, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful treatments for patients, today announced the acceptance of a late-breaking abstract titled “Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors” for presentation at the American Association for Cancer Research (AACR) meeting taking place April 5-10, 2024 in San Diego, CA.

Key Points: 
  • CAMBRIDGE, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- Mestag Therapeutics (“Mestag”), a biotech company harnessing new insights into fibroblast-immune interactions to develop impactful treatments for patients, today announced the acceptance of a late-breaking abstract titled “Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors” for presentation at the American Association for Cancer Research (AACR) meeting taking place April 5-10, 2024 in San Diego, CA.

Lightbridge Provides Business Update and Announces Fiscal Year 2023 Financial Results

Retrieved on: 
Mercredi, février 28, 2024

RESTON, Va,, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the fiscal year ended December 31, 2023, and provided an update on the Company’s continued progress.

Key Points: 
  • RESTON, Va,, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the fiscal year ended December 31, 2023, and provided an update on the Company’s continued progress.
  • Cash provided by financing activities for the year ended December 31, 2023, was $6.2 million, a decrease of $4.7 million, compared to $10.9 million for the year ended December 31, 2022.
  • Stockholders’ equity was $28.9 million at December 31, 2023, as compared to $29.1 million at December 31, 2022.
  • This $0.4 million decrease was due to the GAIN voucher project that was completed in the first quarter of 2023.

Lightbridge CEO Seth Grae Issues Update Letter to Shareholders

Retrieved on: 
Mardi, février 27, 2024

RESTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today issued a corporate update in a letter to shareholders from President and CEO Seth Grae.

Key Points: 
  • RESTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Lightbridge Corporation (“Lightbridge”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today issued a corporate update in a letter to shareholders from President and CEO Seth Grae.
  • Ms. Goodman, a recognized national security expert, joined Lightbridge as an independent director, bringing invaluable insights into the intersection of energy and national security.
  • Lightbridge is adopting the Technology Readiness Level (TRL) system to illustrate the progress of its fuel development efforts.
  • Currently, Lightbridge Fuel is positioned at TRL 4-5, indicating a significant phase in our development process.